Literature DB >> 8078948

The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C.

M Shindo1, A M Di Bisceglie, T Akatsuka, T L Fong, L Scaglione, M Donets, J H Hoofnagle, S M Feinstone.   

Abstract

Negative strands of the hepatitis C virus (HCV) genome (a positive-stranded RNA virus) have been found in a nuclease-resistant form in the serum of patients with HCV infections. We determined whether a complete negative-strand copy is present in the serum, whether the negative strand is particle-associated, and finally, whether it is virion-associated and encapsidated like the positive (genomic) strand. Isopyknic sucrose and cesium chloride density ultracentrifugation followed by a strand-specific reverse transcription-polymerase chain reaction on the collected fractions was performed to determine whether both positive and negative strands were associated with similar particles. Both strands comigrated to approximately the same density (1.11-1.16 g/cm3) in sucrose. After treatment of the plasma with detergent (0.1% Nonidet P-40) to remove the viral envelope and centrifugation on cesium chloride gradients, the positive strands shifted to a density of 1.35 g/cm3, and the negative strands were not detected. By using antibodies specific for the HCV core or envelope glycoproteins E1 or E2 coated onto the wells of a microtiter plate, it was possible to specifically bind HCV or viral cores to the solid phase. Pelleted virus particles were resuspended in either PBS or PBS with 0.1% Nonidet P-40 to expose the core. These pellets were then incubated in antibody-coated microtiter wells. RNA extracted from the bound and unbound fractions was tested for HCV RNA. The anti-core antibody was able to bind positive strands but not negative strands only in detergent-treated samples. In the nondetergent-treated pellets, the anti-E1 and -E2 bound the positive strand, but only anti-E1 bound the negative strands. These findings indicate that while both strands of HCV RNA can be detected in serum, the positive strand is encapsidated within the enveloped core, and the negative strand appears to be in a membrane particle associated with the viral envelope protein E1 but does not appear to be within the HCV core of circulating virions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8078948      PMCID: PMC44678          DOI: 10.1073/pnas.91.18.8719

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Detection of serum hepatitis C virus RNA.

Authors:  S Kaneko; M Unoura; K Kobayashi; K Kuno; S Murakami; N Hattori
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Early events in hepatitis C virus infection of chimpanzees.

Authors:  Y K Shimizu; A J Weiner; J Rosenblatt; D C Wong; M Shapiro; T Popkin; M Houghton; H J Alter; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

Authors:  P P Ulrich; J M Romeo; P K Lane; I Kelly; L J Daniel; G N Vyas
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

5.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

6.  Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.

Authors:  N Kato; O Yokosuka; M Omata; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan.

Authors:  Y Kubo; K Takeuchi; S Boonmar; T Katayama; Q L Choo; G Kuo; A J Weiner; D W Bradley; M Houghton; I Saito
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

8.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

9.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

Authors:  P Simmonds; L Q Zhang; H G Watson; S Rebus; E D Ferguson; P Balfe; G H Leadbetter; P L Yap; J F Peutherer; C A Ludlam
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

10.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

Authors:  A J Weiner; G Kuo; D W Bradley; F Bonino; G Saracco; C Lee; J Rosenblatt; Q L Choo; M Houghton
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

View more
  12 in total

1.  Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization.

Authors:  S Schmolke; M Tacke; U Schmitt; A M Engel; B Ofenloch-Haehnle
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.

Authors:  T F Baumert; S Ito; D T Wong; T J Liang
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus.

Authors:  M Fogeda; S Navas; J Martín; M Casqueiro; E Rodríguez; C Arocena; V Carreño
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells.

Authors:  J Xiang; S Wünschmann; W Schmidt; J Shao; J T Stapleton
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Formation of native hepatitis C virus glycoprotein complexes.

Authors:  V Deleersnyder; A Pillez; C Wychowski; K Blight; J Xu; Y S Hahn; C M Rice; J Dubuisson
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Complement-mediated enhancement of antibody function for neutralization of pseudotype virus containing hepatitis C virus E2 chimeric glycoprotein.

Authors:  Keith Meyer; Arnab Basu; Craig T Przysiecki; L Martin Lagging; Adrian M Di Bisceglie; Anthony J Conley; Ranjit Ray
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

8.  Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells.

Authors:  H Lerat; F Berby; M A Trabaud; O Vidalin; M Major; C Trépo; G Inchauspé
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

Review 9.  Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  Virol J       Date:  2011-07-11       Impact factor: 4.099

10.  Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients.

Authors:  Søren U Nielsen; Margaret F Bassendine; Alastair D Burt; Caroline Martin; Wanna Pumeechockchai; Geoffrey L Toms
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.